The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research

Benjamin I Goldstein, Boris Birmaher, Gabrielle A Carlson, Melissa P DelBello, Robert L Findling, Mary Fristad, Robert A Kowatch, David J Miklowitz, Fabiano G Nery, Guillermo Perez-Algorta, Anna Van Meter, Cristian P Zeni, Christoph U Correll, Hyo-Won Kim, Janet Wozniak, Kiki D Chang, Manon Hillegers, Eric A Youngstrom, Benjamin I Goldstein, Boris Birmaher, Gabrielle A Carlson, Melissa P DelBello, Robert L Findling, Mary Fristad, Robert A Kowatch, David J Miklowitz, Fabiano G Nery, Guillermo Perez-Algorta, Anna Van Meter, Cristian P Zeni, Christoph U Correll, Hyo-Won Kim, Janet Wozniak, Kiki D Chang, Manon Hillegers, Eric A Youngstrom

Abstract

Objectives: Over the past two decades, there has been tremendous growth in research regarding bipolar disorder (BD) among children and adolescents (ie, pediatric BD [PBD]). The primary purpose of this article is to distill the extant literature, dispel myths or exaggerated assertions in the field, and disseminate clinically relevant findings.

Methods: An international group of experts completed a selective review of the literature, emphasizing areas of consensus, identifying limitations and gaps in the literature, and highlighting future directions to mitigate these gaps.

Results: Substantial, and increasingly international, research has accumulated regarding the phenomenology, differential diagnosis, course, treatment, and neurobiology of PBD. Prior division around the role of irritability and of screening tools in diagnosis has largely abated. Gold-standard pharmacologic trials inform treatment of manic/mixed episodes, whereas fewer data address bipolar depression and maintenance/continuation treatment. Adjunctive psychosocial treatment provides a forum for psychoeducation and targets primarily depressive symptoms. Numerous neurocognitive and neuroimaging studies, and increasing peripheral biomarker studies, largely converge with prior findings from adults with BD.

Conclusions: As data have accumulated and controversy has dissipated, the field has moved past existential questions about PBD toward defining and pursuing pressing clinical and scientific priorities that remain. The overall body of evidence supports the position that perceptions about marked international (US vs elsewhere) and developmental (pediatric vs adult) differences have been overstated, although additional research on these topics is warranted. Traction toward improved outcomes will be supported by continued emphasis on pathophysiology and novel therapeutics.

Keywords: adolescent; bipolar disorder; child; pediatric; youth.

© 2017 The Authors Bipolar Disorders Published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Articles about pediatric bipolar disorder indexed in PubMed each year. Search terms were (“bipolar disorder” or mania or manic) and (child or adole* or pediatric or juvenile)

References

    1. Van Meter AR, Moreira AL, Youngstrom EA. Meta‐analysis of epidemiological studies of bipolar disorder. J Clin Psychiatry. 2011;72:1250‐1256.
    1. Andrade N, Hishinuma E, McDermott J, et al. The National Center on Indigenous Hawaiian Behavioral Health Study of Prevalence of Psychiatric Disorders in Native Hawaiian Adolescents. J Am Acad Child Adolesc Psychiatry. 2006;45:26‐36.
    1. Anselmi L, Fleitlich‐Bilyk B, Menezes A, Araújo C, Rohde L. Prevalence of psychiatric disorders in a Brazilian birth cohort of 11‐year‐olds. Soc Psychiatry Psychiatr Epidemiol. 2010;45:135‐142.
    1. Benjet C, Borges G, Medina‐Mora ME, Zambrano J, Aguilar‐Gaxiola S. Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey. J Child Psychol Psychiatry. 2009;50:386‐395.
    1. Canals J, Domenech E, Carbajo G, Blade J. Prevalence of DSM‐III‐R and ICD‐10 psychiatric disorders in a Spanish population of 18‐year‐olds. Acta Psychiatr Scand. 1997;96:287‐294.
    1. Costello EJ, Angold A, Burns BJ, et al. The Great Smoky Mountains Study of Youth: goals, design, methods, and the prevalence of DSM‐III‐R disorders. Arch Gen Psychiatry. 1996;53:1129‐1136.
    1. Gould M, King R, Greenwald S, et al. Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37:915‐923.
    1. Kessler R, Avenevoli S, Green J, et al. National Comorbidity Survey Replication Adolescent Supplement (NCS‐A): III. Concordance of DSM‐IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry. 2009;48:386‐399.
    1. Kim‐Cohen J, Caspi A, Moffitt T, Harrington H, Milne B, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow‐back of a prospective‐longitudinal cohort. Arch Gen Psychiatry. 2003;60:709‐717.
    1. Lewinsohn P, Klein D, Seeley J. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34:454‐463.
    1. Lynch F, Mills C, Daly I, Fitzpatrick C. Challenging times: prevalence of psychiatric disorders and suicidal behaviours in Irish adolescents. J Adolesc. 2006;29:555‐573.
    1. Päären A. Hypomania spectrum disorder in adolescence: a 15‐year follow‐up of non‐mood morbidity in adulthood. BMC Psychiatry. 2014;14:9.
    1. Pan PM, Salum GA, Gadelha A, et al. Manic symptoms in youth: dimensions, latent classes, and associations with parental psychopathology. J Am Acad Child Adolesc Psychiatry. 2014;53:625‐634.
    1. Stringaris A, Santosh P, Leibenluft E, Goodman R. Youth meeting symptom and impairment criteria for mania‐like episodes lasting less than four days: an epidemiological enquiry. J Child Psychol Psychiatry. 2009;51:31‐38.
    1. Tijssen MJ, Van Os J, Wittchen HU, Lieb R, Beesdo K, Wichers M. Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatr Scand. 2010;122:255‐266.
    1. Verhulst F, Van der Ende J, Ferdinand R, Kasius M. The prevalence of DSM‐III‐R diagnoses in a national sample of Dutch adolescents. Arch Gen Psychiatry. 1997;54:329‐336.
    1. Kozloff N, Cheung AH, Schaffer A, et al. Bipolar disorder among adolescents and young adults: results from an epidemiological sample. J Affect Disord. 2010;125:350‐354.
    1. Oh J, Chang JG, Lee SB, Song DH, Cheon KA. Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability. Clin Psychopharmacol Neurosci. 2013;11:72‐79.
    1. Shon SH, Joo Y, Park J, Youngstrom EA, Kim HW. Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review. Eur Child Adolesc Psychiatry. 2013;23:307‐316.
    1. Oh H‐J, Glutting JJ, McDermott PA. An epidemiological‐cohort study of DAS processing speed factor: how well does it identify concurrent achievement and behavior problems? J Psychoeduc Assess. 1999;17:362‐375.
    1. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64:1032‐1039.
    1. Blader JC, Carlson GA. Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996‐2004. Biol Psychiat. 2007;62:107‐114.
    1. Dubicka B, Carlson GA, Vail A, Harrington R. Prepubertal mania: diagnostic differences between US and UK clinicians. Eur Child Adolesc Psychiatry. 2008;17:153‐161.
    1. Costello EJ, Egger H, Angold A. 10‐year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden. J Am Acad Child Adolesc Psychiatry. 2005;44:972‐986.
    1. Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014;16:478‐492.
    1. Post RM, Ballenger JC, Rey AC, Bunney WE Jr. Slow and rapid onset of manic episodes: implications for underlying biology. Psychiatry Res. 1981;4:229‐237.
    1. Bellivier F, Etain B, Malafosse A, et al. Age at onset in bipolar I affective disorder in the USA and Europe. World J Biol Psychiatry. 2014;15:369‐376.
    1. Post RM, Luckenbaugh DA, Leverich GS, et al. Incidence of childhood‐onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008;192:150‐151.
    1. Post RM, Leverich GS, Kupka R, et al. Increased parental history of bipolar disorder in the United States: association with early age of onset. Acta Psychiatr Scand. 2014;129:375‐382.
    1. Diler RS. Pediatric Bipolar Disorder: A Global Perspective. New York: Nova Science; 2007.
    1. Masi G, Perugi G, Millepiedi S, et al. Clinical implications of DSM‐IV subtyping of bipolar disorders in referred children and adolescents. J Am Acad Child Adolesc Psychiatry. 2007;46:1299‐1306.
    1. Diler RS, Uguz S, Seydaoglu G, Erol N, Avci A. Differentiating bipolar disorder in Turkish prepubertal children with attention‐deficit hyperactivity disorder. Bipolar Disord. 2007;9:243‐251.
    1. Benarous X, Mikita N, Goodman R, Stringaris A. Distinct relationships between social aptitude and dimensions of manic‐like symptoms in youth. Eur Child Adolesc Psychiatry. 2016;25:831‐842.
    1. Masi G, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS. Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry. 2001;46:797‐802.
    1. Jairam R, Srinath S, Girimaji SC, Seshadri SP. A prospective 4‐5 year follow‐up of juvenile onset bipolar disorder. Bipolar Disord. 2004;6:386‐394.
    1. Srinath S, Janardhan Reddy YC, Girimaji SR, Seshadri SP, Subbakrishna DK. A prospective study of bipolar disorder in children and adolescents from India. Acta Psychiatr Scand. 1998;98:437‐442.
    1. Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention‐ deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol. 2009;19:553‐561.
    1. Masi G, Perugi G, Millepiedi S, et al. Pharmacological response in juvenile bipolar disorder subtypes: a naturalistic retrospective examination. Psychiatry Res. 2010;177:192‐198.
    1. Zeni CP, Tramontina S, Zeni TA, et al. The Val66Met polymorphism at the BDNF gene does not influence Wisconsin Card Sorting Test results in children and adolescents with bipolar disorder. Rev Bras Psiquiatr. 2013;35:44‐50.
    1. Lauxen Peruzzolo T, Anes M, Kohmann Ade M, et al. Correlation between peripheral levels of brain‐derived neurotrophic factor and hippocampal volume in children and adolescents with bipolar disorder. Neural Plast. 2015;2015:324825.
    1. Zeni CP, Tramontina S, Aguiar BW, et al. BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention‐deficit/hyperactivity disorder. Acta Psychiatr Scand. 2016;134:268‐274.
    1. Manon HJH, Catrien GR, Marjolein W, Frank CV, Johan O, Willem AN. Five‐year prospective outcome of psychopathology in the adolescent offspring of bipolar parents. Bipolar Disord. 2005;7:344‐350.
    1. Grigoroiu‐Serbanescu M, Christodorescu D, Jipescu I, Totoescu A, Marinescu E, Ardelean V. Psychopathology in children aged 10‐17 of bipolar parents: psychopathology rate and correlates of the severity of the psychopathology. J Affect Disord. 1989;16:167‐179.
    1. Galanter CA, Hundt SR, Goyal P, Le J, Fisher PW. Variability among research diagnostic interview instruments in the application of DSM‐IV‐TR criteria for pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2012;51:605‐621.
    1. Galanter CA, Patel VL. Medical decision making: a selective review for child psychiatrists and psychologists. J Child Psychol Psychiatry. 2005;46:675‐689.
    1. Carlson GA. Disruptive mood dysregulation disorder: where did it come from and where is it going. J Child Adolesc Psychopharmacol. 2016;26:90‐93.
    1. Nader EG, Kleinman A, Gomes BC, et al. Negative expressed emotion best discriminates families with bipolar disorder children. J Affect Disord. 2013;148:418‐423.
    1. Teixeira AM, Kleinman A, Zanetti M, et al. Preserved white matter in unmedicated pediatric bipolar disorder. Neurosci Lett. 2014;579:41‐45.
    1. Lee HJ, Joo Y, Youngstrom EA, Yum SY, Findling RL, Kim HW. Diagnostic validity and reliability of a Korean version of the Parent and Adolescent General Behavior Inventories. Compr Psychiatry. 2014;55:1730‐1737.
    1. Mesman E, Birmaher BB, Goldstein BI, et al. Categorical and dimensional psychopathology in Dutch and US offspring of parents with bipolar disorder: a preliminary cross‐national comparison. J Affect Disord. 2016;205:95‐102.
    1. Achenbach TM, Rescorla LA. Manual for the ASEBA School‐Age Forms & Profiles. Burlington, VT: University of Vermont; 2001.
    1. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School‐Age Children‐Present and Lifetime version (K‐SADS‐PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980‐988.
    1. Youngstrom EA, Genzlinger JE, Egerton GA, Van Meter AR. Multivariate meta‐analysis of the discriminative validity of caregiver, youth, and teacher rating scales for pediatric bipolar disorder: mother knows best about mania. Arch Sci Psychol. 2015;3:112‐137.
    1. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160:430‐437.
    1. Axelson DA, Birmaher B, Findling RL, et al. Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the diagnostic and statistical manual of mental disorders, fifth edition. J Clin Psychiatry. 2011;72:1257‐1262. .
    1. Geller B, Craney JL, Bolhofner K, DelBello MP, Williams M, Zimerman B. One‐year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2001;158:303‐305.
    1. Carlson GA, Klein DN. How to understand divergent views on bipolar disorder in youth. Annu Rev Clin Psychol. 2014;10:529‐551.
    1. Hunt J, Birmaher B, Leonard H, et al. Irritability without elation in a large bipolar youth sample: frequency and clinical description. J Am Acad Child Adolesc Psychiatry. 2009;48:730‐739.
    1. Fonseka TM, Swampillai B, Timmins V, et al. Significance of borderline personality‐spectrum symptoms among adolescents with bipolar disorder. J Affect Disord. 2015;170:39‐45.
    1. Mitchell RHB, Timmins V, Collins J, Scavone A, Iskric A, Goldstein BI. Prevalence and correlates of disruptive mood dysregulation disorder among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2016;26:147‐153.
    1. Fristad MA, Wolfson H, Algorta GP, et al. Disruptive mood dysregulation disorder and bipolar disorder not otherwise specified: fraternal or identical twins? J Child Adolesc Psychopharmacol. 2016;26:138‐146.
    1. Merikangas KR, Jin R, He J‐P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241‐251.
    1. Van Meter AR, Youngstrom EA, Findling RL. Cyclothymic disorder: a critical review. Clin Psychol Rev. 2012;32:229‐243.
    1. Axelson DA, Birmaher B, Strober MA, et al. Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry. 2011;50:1001‐1016.
    1. Axelson D, Birmaher B, Strober M, et al. Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:1139‐1148.
    1. Van Meter A, Youngstrom EA, Demeter C, Findling RL. Examining the validity of cyclothymic disorder in a youth sample: replication and extension. J Abnorm Child Psychol. 2013;41:367‐378.
    1. Geller B, Zimerman B, Williams M, et al. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2000;10:157‐164.
    1. Youngstrom EA, Birmaher B, Findling RL. Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord. 2008;10:194‐214.
    1. Merikangas KR, J‐p H, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication‐Adolescent Supplement (NCS‐A). J Am Acad Child Adolesc Psychiatry. 2010;49:980‐989.
    1. Wittchen HU, Frohlich C, Behrendt S, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10‐year prospective‐longitudinal community study in adolescents. Drug Alcohol Depend. 2007;88(Suppl 1):S60‐S70.
    1. Van Meter AR, Burke C, Kowatch RA, Findling RL, Youngstrom EA. Ten‐year updated meta‐analysis of the clinical characteristics of pediatric mania and hypomania. Bipolar Disord. 2016;18:19‐32.
    1. Birmaher B, Axelson D, Strober M, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:175‐183.
    1. Sachs GS, Baldassano CF, Truman CJ, Guille C. Comorbidity of attention deficit hyperactivity disorder with early‐ and late‐onset bipolar disorder. Am J Psychiatry. 2000;157:466‐468.
    1. Nierenberg AA, Miyahara S, Spencer T, et al. Clinical and diagnostic implications of lifetime attention‐deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP‐BD participants. Biol Psychiat. 2005;57:1467‐1473.
    1. Goldstein BI, Blanco C, He J‐P, Merikangas K. Correlates of overweight and obesity among adolescents with bipolar disorder in the National Comorbidity Survey‐Adolescent Supplement (NCS‐A). J Am Acad Child Adolesc Psychiatry. 2016;55:1020‐1026.
    1. Shapiro J, Mindra S, Timmins V, et al. Controlled study of obesity among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2016;27:95‐100.
    1. Naiberg MR, Newton DF, Collins JE, Bowie CR, Goldstein BI. Impulsivity is associated with blood pressure and waist circumference among adolescents with bipolar disorder. J Psychiatr Res. 2016;83:230‐239.
    1. Naiberg MR, Newton DF, Collins JE, Dickstein DP, Bowie CR, Goldstein BI. Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder. Acta Psychiatr Scand. 2016;134:241‐248.
    1. Goldstein BI, Carnethon MR, Matthews KA, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a Scientific Statement From the American Heart Association. Circulation. 2015;132:965‐986.
    1. Martin K, Woo J, Timmins V, et al. Binge eating and emotional eating behaviors among adolescents and young adults with bipolar disorder. J Affect Disord. 2016;195:88‐95.
    1. Jewell L, Abtan R, Scavone A, Timmins V, Swampillai B, Goldstein BI. Preliminary evidence of disparities in physical activity among adolescents with bipolar disorder. Ment Health Phys Act. 2015;8:62‐67.
    1. APA . Diagnostic and Statistical Manual of Mental Disorders. 5th edn Arlington, VA: American Psychiatric Publishing; 2013.
    1. Axelson D, Findling RL, Fristad MA, et al. Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry. 2012;73:1342‐1350.
    1. Freeman AJ, Youngstrom EA, Youngstrom JK, Findling RL. Disruptive mood dysregulation disorder in a community mental health clinic: prevalence, comorbidity and correlates. J Child Adolesc Psychopharmacol. 2016;26:123‐130.
    1. Copeland WE, Shanahan L, Egger H, Angold A, Costello EJ. Adult diagnostic and functional outcomes of DSM‐5 disruptive mood dysregulation disorder. Am J Psychiatry. 2014;171:668‐674.
    1. Mayes SD, Waxmonsky JD, Calhoun SL, Bixler EO. Disruptive mood dysregulation disorder symptoms and association with oppositional defiant and other disorders in a general population child sample. J Child Adolesc Psychopharmacol. 2016;26:101‐106.
    1. Birmaher B, Axelson D, Goldstein B, et al. Four‐year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166:795‐804.
    1. Shankman SA, Lewinsohn PM, Klein DN, Small JW, Seeley JR, Altman SE. Subthreshold conditions as precursors for full syndrome disorders: a 15‐year longitudinal study of multiple diagnostic classes. J Child Psychol Psychiatry. 2009;50:1485‐1494.
    1. Wozniak J, Petty CR, Schreck M, Moses A, Faraone SV, Biederman J. High level of persistence of pediatric bipolar‐I disorder from childhood onto adolescent years: a four year prospective longitudinal follow‐up study. J Psychiatr Res. 2011;45:1273‐1282.
    1. Geller B, Tillman R, Bolhofner K, Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8‐year outcome. Arch Gen Psychiatry. 2008;65:1125‐1133.
    1. Kowatch RA, Youngstrom EA, Danielyan A, Findling RL. Review and meta‐analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord. 2005;7:483‐496.
    1. McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:107‐125.
    1. Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU. The bipolar prodrome: meta‐analysis of symptom prevalence prior to initial or recurrent mood episodes. J Am Acad Child Adolesc Psychiatry. 2016;55:543‐555.
    1. Tillman R, Geller B. Controlled study of switching from attention‐deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6‐year prospective follow‐up: rate, risk, and predictors. Dev Psychopathol. 2006;18:1037‐1053.
    1. Biederman J, Petty CR, Byrne D, Wong P, Wozniak J, Faraone SV. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study. J Affect Disord. 2009;119:16‐21.
    1. Molina BSG, Hinshaw SP, Swanson JM, et al. The MTA at 8 Years. J Am Acad Child Adolesc Psychiatry. 2009;48:484‐500.
    1. Evans SC, Burke JD, Roberts MC, et al. Irritability in child and adolescent psychopathology: an integrative review for ICD‐11. Clin Psychol Rev. 2017;53:29‐45.
    1. Dickstein DP, Towbin KE, Van Der Veen JW, et al. Randomized double‐blind placebo‐controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol. 2009;19:61‐73.
    1. Cicero DC, Epler AJ, Sher KJ. Are there developmentally limited forms of bipolar disorder? J Abnorm Psychol. 2009;118:431‐447.
    1. Jensen‐Doss A, Youngstrom EA, Youngstrom JK, Feeny NC, Findling RL. Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents. J Consult Clin Psychol. 2014;82:1151‐1162.
    1. Rettew DC, Lynch AD, Achenbach TM, Dumenci L, Ivanova MY. Meta‐analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews. Int J Methods Psychiatr Res. 2009;18:169‐184.
    1. Jenkins MM, Youngstrom EA, Washburn JJ, Youngstrom JK. Evidence‐based strategies improve assessment of pediatric bipolar disorder by community practitioners. Prof Psychol Res Pr. 2011;42:121‐129.
    1. Achenbach TM, McConaughy SH, Howell CT. Child/Adolescent behavioral and emotional problems: implication of cross‐informant correlations for situational specificity. Psychol Bull. 1987;101:213‐232.
    1. Althoff RR, Ayer LA, Rettew DC, Hudziak JJ. Assessment of dysregulated children using the Child Behavior Checklist: a receiver operating characteristic curve analysis. Psychol Assess. 2010;22:609‐617.
    1. Diler RS, Birmaher B, Axelson D, et al. The Child Behavior Checklist (CBCL) and the CBCL‐bipolar phenotype are not useful in diagnosing pediatric bipolar disorder. J Child Adolesc Psychopharmacol. 2009;19:23‐30.
    1. Youngstrom EA, Findling RL, Danielson CK, Calabrese JR. Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory. Psychol Assess. 2001;13:267‐276.
    1. Youngstrom EA, Frazier TW, Findling RL, Calabrese JR. Developing a ten item short form of the Parent General Behavior Inventory to assess for juvenile mania and hypomania. J Clin Psychiatry. 2008;69:831‐839.
    1. Pavuluri MN, Henry DB, Devineni B, Carbray JA, Birmaher B. Child mania rating scale: development, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 2006;45:550‐560.
    1. Henry DB, Pavuluri MN, Youngstrom E, Birmaher B. Accuracy of brief and full forms of the Child Mania Rating Scale. J Clin Psychol. 2008;64:368‐381.
    1. Wagner KD, Kowatch RA, Emslie GJ, et al. A double‐blind, randomized, placebo‐controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006;163:1179‐1186.
    1. Straus SE, Glasziou P, Richardson WS, Haynes RB. Evidence‐based medicine: How to practice and teach EBM, 4th edn New York, NY: Churchill Livingstone; 2011.
    1. Jenkins MM, Youngstrom EA, Youngstrom JK, Feeny NC, Findling RL. Generalizability of evidence‐based assessment recommendations for pediatric bipolar disorder. Psychol Assess. 2012;24:269‐281.
    1. West AE, Celio CI, Henry DB, Pavuluri MN. Child Mania Rating Scale‐Parent Version: a valid measure of symptom change due to pharmacotherapy. J Affect Disord. 2011;128:112‐119.
    1. Youngstrom EA, Zhao J, Mankoski R, et al. Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder. J Child Adolesc Psychopharmacol. 2013;23:72‐79.
    1. Geller B, Zimerman B, Williams M, et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH‐U‐KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry. 2001;40:450‐455.
    1. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429‐435.
    1. Poznanski EO, Miller E, Salguero C, Kelsh RC. Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Psychiatry. 1984;23:191‐197.
    1. Axelson DA, Birmaher BJ, Brent D, et al. A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School‐Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol. 2003;13:463‐470.
    1. Demeter CA, Youngstrom EA, Carlson GA, et al. Age differences in the phenomenology of pediatric bipolar disorder. J Affect Disord. 2013;147:295‐303.
    1. Yee AM, Algorta GP, Youngstrom EA, et al. Unfiltered administration of the YMRS and CDRS‐R in a clinical sample of children. J Clin Child Adolesc Psychol. 2015;44:992‐1007.
    1. Suppiger A, In‐Albon T, Hendriksen S, Hermann E, Margraf J, Schneider S. Acceptance of structured diagnostic interviews for mental disorders in clinical practice and research settings. Behav Ther. 2009;40:272‐279.
    1. Algorta GP, Youngstrom EA, Phelps J, Jenkins MM, Youngstrom JK, Findling RL. An inexpensive family index of risk for mood issues improves identification of pediatric bipolar disorder. Psychol Assess. 2013;25:12‐22.
    1. Miklowitz DJ, Axelson DA, George EL, et al. Expressed emotion moderates the effects of family‐focused treatment for bipolar adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48:643‐651.
    1. Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP. Pharmacotherapy of bipolar disorder in children and adolescents: an update. Rev Bras Psiquiatr. 2013;35:393‐405.
    1. Goldstein BI, Sassi R, Diler RS. Pharmacological treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012;21:911‐939.
    1. Singh MK, Ketter TA, Chang KD. Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder. Drugs. 2010;70:433‐442.
    1. Kowatch R, Findling R, Scheffer R, Stanford K. Placebo controlled trial of divalproex versus lithium for bipolar disorder. Boston, MA: American Academy of Child and Adolescent Psychiatry 54th Annual Meeting; 2007.
    1. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short‐term trials. J Am Acad Child Adolesc Psychiatry. 2007;46:687‐700.
    1. Liu HY, Potter MP, Woodworth KY, et al. Pharmacologic treatments for pediatric bipolar disorder: a review and meta‐analysis. J Am Acad Child Adolesc Psychiatry. 2011;50:749‐762.
    1. Findling RL, Robb A, McNamara NK, et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics. 2015;136:885‐894.
    1. Wagner KD, Redden L, Kowatch RA, et al. A double‐blind, randomized, placebo‐controlled trial of divalproex extended‐release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48:519‐532.
    1. Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo‐controlled trials. Bipolar Disord. 2010;12:116‐141.
    1. Delbello MP, Findling RL, Kushner S, et al. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:539‐547.
    1. Tramontina S, Zeni CP, Pheula G, Rohde LA. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial. J Child Adolesc Psychopharmacol. 2007;17:129‐134.
    1. Geller B, Luby JL, Joshi P, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69:515‐528.
    1. Vitiello B, Riddle MA, Yenokyan G, et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry. 2012;51:867‐878.
    1. Stringaris A. What we can all learn from the Treatment of Early Age Mania (TEAM) trial. J Am Acad Child Adolesc Psychiatry. 2012;51:861‐863.
    1. Detke HC, DelBello MP, Landry J, Usher RW. Olanzapine/fluoxetine combination in children and adolescents with bipolar i depression: a randomized, double‐blind, placebo‐controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54:217‐224.
    1. Delbello MP, Goldman R, Phillips D, Deng L, Cucchiaro J, Loebel A. Efficacy and Safety of Lurasidone in Children and Adolescent Patients with Bipolar I Depression. Presented at the annual meeting of the International Society for Bipolar Disorders, May 4–7 2017, Washington DC.
    1. Findling RL, Pathak S, Earley WR, Liu S, DelBello MP. Efficacy and safety of extended‐release quetiapine fumarate in youth with bipolar depression: an 8 week, double‐blind, placebo‐controlled trial. J Child Adolesc Psychopharmacol. 2014d;24:325‐335.
    1. DelBello MP, Chang K, Welge JA, et al. A double‐blind, placebo‐controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord. 2009;11:483‐493.
    1. Patel NC, DelBello MP, Bryan HS, et al. Open‐label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006;45:289‐297.
    1. Chang K, Saxena K, Howe M. An open‐label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006;45:298‐304.
    1. Shon SH, Joo Y, Lee JS, Kim HW. Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review. J Child Adolesc Psychopharmacol. 2014;24:285‐287.
    1. Goldsmith M, Singh M, Chang K. Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Paediatr Drugs. 2011;13:225‐243.
    1. Park KJ, Shon S, Lee HJ, Joo Y, Youngstrom EA, Kim HW. Antidepressant‐emergent mood switch in korean adolescents with mood disorder. Clin Neuropharmacol. 2014;37:177‐185.
    1. Bhowmik D, Aparasu RR, Rajan SS, Sherer JT, Ochoa‐Perez M, Chen H. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression. J Child Adolesc Psychopharmacol. 2014;24:551‐561.
    1. Strober M, Schmidt‐Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M. Recovery and relapse in adolescents with bipolar affective illness: a five‐year naturalistic, prospective follow‐up. J Am Acad Child Adolesc Psychiatry. 1995;34:724‐731.
    1. Findling RL, McNamara NK, Youngstrom EA, et al. Double‐blind 18‐month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:409‐417.
    1. Redden L, DelBello M, Wagner KD, et al. Long‐term safety of divalproex sodium extended‐release in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol. 2009;19:83‐89.
    1. Findling RL, Youngstrom EA, McNamara NK, et al. Double‐blind, randomized, placebo‐controlled long‐term maintenance study of aripiprazole in children with bipolar disorder. J Clin Psychiatry. 2012;73:57‐63.
    1. Findling RL, Correll CU, Nyilas M, et al. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study. Bipolar Disord. 2013;15:138‐149.
    1. Findling RL, Chang K, Robb A, et al. Adjunctive maintenance lamotrigine for pediatric bipolar I disorder: a placebo‐controlled, randomized withdrawal study. J Am Acad Child Adolesc Psychiatry. 2015;54:1020.e3‐1031.e3.
    1. Findling RL, Landbloom RL, Mackle M, et al. Long‐term safety of asenapine in pediatric patients diagnosed with bipolar I disorder: a 50‐week open‐label, flexible‐dose trial. Pediatr Drugs. 2016;18:367‐378.
    1. Scheffer RE, Kowatch RA, Carmody T, Rush AJ. Randomized, placebo‐controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162:58‐64.
    1. Findling RL, Short EJ, McNamara NK, et al. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention‐deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:1445‐1453.
    1. Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention‐deficit/hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry. 2009;70:756‐764.
    1. Hah M, Chang K. Atomoxetine for the treatment of attention‐deficit/hyperactivity disorder in children and adolescents with bipolar disorders. J Child Adolesc Psychopharmacol. 2005;15:996‐1004.
    1. Geller B, Cooper TB, Sun K, et al. Double‐blind and placebo‐controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37:171‐178.
    1. Wozniak J, Biederman J, Mick E, et al. Omega‐3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open‐label trial. Eur Neuropsychopharmacol. 2007;17:440‐447.
    1. Frazier EA, Fristad MA, Arnold LE. Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J Altern Complement Med. 2012;18:678‐685.
    1. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long‐chain [omega]‐3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr. 2009;63:1037‐1040.
    1. Fristad MA, Young AS, Vesco AT, et al. A randomized controlled trial of individual family psychoeducational psychotherapy and omega‐3 fatty acids in youth with subsyndromal bipolar disorder. J Child Adolesc Psychopharmacol. 2015;25:764‐774.
    1. Gracious BL, Chirieac MC, Costescu S, Finucane TL, Youngstrom EA, Hibbeln JR. Randomized, placebo‐controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord. 2010;12:142‐154.
    1. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381:1672‐1682.
    1. Colom F, Vieta E, Martinez‐Aran A, Reinares M, Goikolea JM, Martínez‐Arán A. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of bipolar disorder: a five year follow‐up. Br J Psychiatry. 2009;194:260‐265.
    1. Bauer MS, McBride L, Williford W, et al. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006;57:937‐945.
    1. Simon GE, Ludman EJ, Bauer MS, Unutzer J, Operskalski B. Long‐term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry. 2006;63:500‐508.
    1. Frank E, Kupfer DJ, Thase ME, et al. Two‐year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62:996‐1004.
    1. Fristad MA, MacPherson H. Evidence‐based psychosocial treatments for bipolar disorder in youth. J Clin Child Adolesc Psychol. 2014;43:339‐355.
    1. Goldstein TR, Fersch‐Podrat RK, Rivera M, et al. Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial. J Child Adolesc Psychopharmacol. 2015;25:140‐149.
    1. Miklowitz DJ, O'Brien MP, Schlosser DA, et al. Family‐focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014a;53:848‐858.
    1. West AE, Weinstein SM, Peters AT, et al. Child‐and family‐focused cognitive‐behavioral therapy for pediatric bipolar disorder: a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2014;53:1168‐1178.
    1. Goldstein BI, Goldstein TR, Miklowitz DJ, et al. Development of integrated family ‐focused treatment (FFT) for adolescents with bipolar disorder and comorbid substance use disorders. Phoenix, AZ: NCDEU; 2008.
    1. Miklowitz DJ, Schneck CD, George EL, et al. A 2‐year randomized trial of pharmacotherapy and family‐focused treatment for adolescents with bipolar I and II disorders. Am J Psychiatry. 2014b;171:658‐667.
    1. Fristad MA. Evidence‐based psychotherapies and nutritional interventions for children with bipolar spectrum disorders and their families. J Clin Psychiatry. 2016;77:e4.
    1. Hlastala SA, Kotler JS, McClellan JM, McCauley EA. Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial. Depress Anxiety. 2010;27:457‐464.
    1. MacPherson HA, Mackinaw‐Koons B, Leffler JM, Fristad MA. Pilot effectiveness evaluation of community‐based multi‐family psychoeducational psychotherapy for childhood mood disorders. Couple Family Psychol. 2016;5:43‐59.
    1. MacPherson HA, Leffler JM, Fristad MA. Implementation of multi‐family psychoeducational psychotherapy for childhood mood disorders in an outpatient community setting. J Marital Fam Ther. 2014;40:193‐211.
    1. Mendenhall AN, Fristad MA, Early TJ. Factors influencing service utilization and mood symptom severity in children with mood disorders: effects of multifamily psychoeducation groups (MFPGs). J Consult Clin Psychol. 2009;77:463.
    1. MacPherson HA, Weinstein SM, Henry DB, West AE. Mediators in the randomized trial of Child‐ and Family‐Focused Cognitive‐Behavioral Therapy for pediatric bipolar disorder. Behav Res Ther. 2016;85:60‐71.
    1. MacPherson HA, Algorta GP, Mendenhall AN, Fields BW, Fristad MA. Predictors and moderators in the randomized trial of multi‐family psychoeducational psychotherapy for childhood mood disorders. J Clin Child Adolesc Psychol. 2014;43:459‐472.
    1. Boylan K, MacPherson HA, Fristad MA. Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders. J Am Acad Child Adolesc Psychiatry. 2013;52:699‐708.
    1. Goldstein BI, Goldstein TR, Collinger KA, et al. Treatment development and feasibility study of family‐focused treatment for adolescents with bipolar disorder and comorbid substance use disorders. J Psychiatr Pract. 2014;20:237‐248.
    1. Miklowitz DJ, Schneck CD, Singh MK, et al. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family‐focused therapy. J Am Acad Child Adolesc Psychiatry. 2013;52:121‐131.
    1. Nadkarni RB, Fristad MA. Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord. 2010;12:494‐503.
    1. Strakowski SM, Adler CM, Almeida J, et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012;14:313‐325.
    1. DelBello MP, Kowatch RA. Neuroimaging in Pediatric Bipolar Disorder. Bipolar Disorder in Children and Early Adolescence. New York, NY: Guilford Press; 2003:158‐174.
    1. Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM. Neuroprogression in bipolar disorder. Bipolar Disord. 2012;14:356‐374.
    1. Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry. 2014;171:829‐843.
    1. Pfeifer JC, Welge J, Strakowski SM, Adler CM, DelBello MP. Meta‐analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2008;47:1289‐1298.
    1. Usher J, Leucht S, Falkai P, Scherk H. Correlation between amygdala volume and age in bipolar disorder—a systematic review and meta‐analysis of structural MRI studies. Psychiatry Res. 2010;182:2010.
    1. Bitter SM, Mills NP, Adler CM, Strakowski SM, DelBello MP. Progression of amygdala volumetric abnormalities in adolescents after their first manic episode. J Am Acad Child Adolesc Psychiatry. 2011;50:1017‐1026.
    1. Adler CM, Adams J, DelBello MP, et al. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. Am J Psychiatry. 2006;163:322‐324.
    1. Frazier J, Breeze J, Papadimitriou G, et al. White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord. 2007;9:799‐809.
    1. Pavuluri MN, Yang S, Kamineni K, et al. Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention‐deficit/hyperactivity disorder. Biol Psychiat. 2009;65:586‐593.
    1. Kafantaris V, Kingsley P, Ardekani B, et al. Lower orbital frontal white matter integrity in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:79‐86.
    1. Saxena K, Tamm L, Walley A, et al. A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders. J Child Adolesc Psychopharmacol. 2012;22:112‐119.
    1. Gao W, Jiao Q, Qi R, et al. Combined analyses of gray matter voxel‐based morphometry and white matter tract‐based spatial statistics in pediatric bipolar mania. J Affect Disord. 2013;150:70‐76.
    1. James A, Hough M, James S, et al. Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis. Bipolar Disord. 2011;13:16‐27.
    1. Lu LH, Zhou XJ, Fitzgerald J, et al. Microstructural abnormalities of white matter differentiate pediatric and adult‐onset bipolar disorder. Bipolar Disord. 2012;14:597‐606.
    1. Wegbreit E, Cushman GK, Puzia ME, et al. Developmental meta‐analyses of the functional neural correlates of bipolar disorder. JAMA Psychiatry. 2014;71:926‐935.
    1. Lee MS, Anumagalla P, Talluri P, Pavuluri MN. Meta‐analyses of developing brain function in high‐risk and emerged bipolar disorder. Front Psychiatry. 2014;5:141.
    1. Dickstein DP, Finger EC, Skup M, Pine DS, Blair JR, Leibenluft E. Altered neural function in pediatric bipolar disorder during reversal learning. Bipolar Disord. 2010;12:707‐719.
    1. Singh MK, Chang KD, Kelley RG, et al. Reward processing in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2013;52:68‐83.
    1. Urosevic S, Luciana M, Jensen JB, Youngstrom EA, Thomas KM. Age associations with neural processing of reward anticipation in adolescents with bipolar disorders. Neuroimage Clin. 2016;11:476‐485.
    1. Adler CM, Delbello MP, Mills NP, Schmithorst V, Holland S, Strakowski SM. Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord. 2005;7:577‐588.
    1. Cerullo MA, Adler CM, Lamy M, et al. Differential brain activation during response inhibition in bipolar and attention‐deficit hyperactivity disorders. Early Interv Psychiatry. 2009;3:189‐197.
    1. Leibenluft E, Rich BA, Vinton DT, et al. Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder. Am J Psychiatry. 2007;164:52‐60.
    1. Dickstein DP, Gorrostieta C, Ombao H, et al. Fronto‐temporal spontaneous resting state functional connectivity in pediatric bipolar disorder. Biol Psychiat. 2010;68:839‐846.
    1. Singh MK, Kelley RG, Chang KD, Gotlib IH. Intrinsic amygdala functional connectivity in youth with bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:763‐770.
    1. Xiao Q, Zhong Y, Lu D, et al. Altered regional homogeneity in pediatric bipolar disorder during manic state: a resting‐state fMRI study. PLoS ONE. 2013;8:e57978.
    1. Gao W, Jiao Q, Lu S, et al. Alterations of regional homogeneity in pediatric bipolar depression: a resting‐state fMRI study. BMC Psychiatry. 2014;14:222.
    1. Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol. 2000;21:832‐838.
    1. Moore CM, Frazier JA, Glod CA, et al. Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0‐T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry. 2007;46:524‐534.
    1. Davanzo P, Thomas MA, Yue K, et al. Decreased anterior cingulate myo‐inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology. 2001;24:359‐369.
    1. Davanzo P, Yue K, Thomas MA, et al. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry. 2003;160:1442‐1452.
    1. Cecil KM, DelBello MP, Sellars MC, Strakowski SM. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol. 2003;13:545‐555.
    1. Chang K, Adleman N, Dienes K, Barnea‐Goraly N, Reiss A, Ketter T. Decreased N‐acetylaspartate in children with familial bipolar disorder. Biol Psychiatry. 2003;53:1059‐1065.
    1. Patel NC, DelBello MP, Cecil KM, Stanford KE, Adler CM, Strakowski SM. Temporal change in N‐acetyl‐aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol. 2008;18:132‐139.
    1. Brambilla P, Stanley JA, Nicoletti MA, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord. 2005;86:61‐67.
    1. Caetano SC, Olvera RL, Hatch JP, et al. Lower N‐acetyl‐aspartate levels in prefrontal cortices in pediatric bipolar disorder: a (1)H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry. 2011;50:85‐94.
    1. Sassi RB, Stanley JA, Axelson D, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry. 2005;162:2109‐2115.
    1. Olvera RL, Caetano SC, Fonseca M, et al. Low levels of N‐acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol. 2007;17:461‐473.
    1. Strawn JR, Patel NC, Chu WJ, et al. Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry. 2012;51:642‐651.
    1. DelBello MP, Cecil KM, Adler CM, Daniels JP, Strakowski SM. Neurochemical effects of olanzapaine in first‐hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology. 2006;31:1264‐1273.
    1. Diler RS, Ladouceur CD, Segreti A, et al. Neural correlates of treatment response in depressed bipolar adolescents during emotion processing. Brain Imaging Behav. 2013;7:227‐235.
    1. Schneider MR, Adler CM, Whitsel R, et al. The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder. Isr J Psychiatry Relat Sci. 2012;49:112‐120.
    1. Schneider MR, Klein CC, Weber W, et al. The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder. Psychiatry Res. 2014;223:268‐270.
    1. Wegbreit E, Ellis JA, Nandam A, et al. Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder. Brain Connect. 2011;1:411‐422.
    1. Garrett AS, Miklowitz DJ, Howe ME, et al. Changes in brain activation following psychotherapy for youth with mood dysregulation at familial risk for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015;56:215‐220.
    1. Joseph MF, Frazier TW, Youngstrom EA, Soares JC. A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder”. J Child Adolesc Psychopharmacol. 2008;18:595‐605.
    1. Pavuluri MN, West A, Hill SK, Jindal K, Sweeney JA. Neurocognitive function in pediatric bipolar disorder: 3‐year follow‐up shows cognitive development lagging behind healthy youths. J Am Acad Child Adolesc Psychiatry. 2009;48:299‐307.
    1. Dickstein DP, Cushman GK, Kim KL, Weissman AB, Wegbreit E. Cognitive remediation: potential novel brain‐based treatment for bipolar disorder in children and adolescents. CNS Spectr. 2015;20:382‐390.
    1. Munkholm K, Braüner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta‐analysis. J Psychiatr Res. 2013;47:1119‐1133.
    1. Frey BN, Andreazza AC, Houenou J, et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 2013;47:321‐332.
    1. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35:804‐817.
    1. Kapczinski F, Dias VV, Kauer‐Sant'Anna M, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1366‐1371.
    1. Goldstein BI, Collinger KA, Lotrich F, et al. Preliminary findings regarding pro‐inflammatory markers and brain‐derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol. 2011;21:479‐484.
    1. Goldstein BI, Lotrich F, Axelson DA, et al. Inflammatory markers among adolescents and young adults with bipolar spectrum disorders. J Clin Psychiatry. 2015;76:1556‐1563.
    1. Miklowitz DJ, Portnoff LC, Armstrong CC, et al. Inflammatory cytokines and nuclear factor‐kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res. 2016;241:315‐322.
    1. Hatch JK, Scola G, Olowoyeye O, et al. Inflammatory markers and brain‐derived neurotrophic factor as potential bridges linking bipolar disorder and cardiovascular risk among adolescents. J Clin Psychiatry. 2017;78:e286‐e293.
    1. Hatch J, Andreazza A, Olowoyeye O, Rezin GT, Moody A, Goldstein BI. Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder. J Psychosom Res. 2015;79:222‐227.
    1. Magalhaes PV, Jansen K, Pinheiro RT, et al. Peripheral oxidative damage in early‐stage mood disorders: a nested population‐based case‐control study. Int J Neuropsychopharmacol. 2012;15:1043‐1050.
    1. Scola G, McNamara RK, Croarkin PE, et al. Lipid peroxidation biomarkers in adolescents with or at high‐risk for bipolar disorder. J Affect Disord. 2016;192:176‐183.
    1. Newton DF, Naiberg MR, Andreazza AC, Scola G, Dickstein DP, Goldstein BI. Association of lipid peroxidation and brain‐derived neurotrophic factor with executive function in adolescent bipolar disorder. Psychopharmacology. 2017;234:647‐656.
    1. Pandey GN, Rizavi HS, Dwivedi Y, Pavuluri MN. Brain‐derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response. J Am Acad Child Adolesc Psychiatry. 2008;47:1077‐1085.
    1. Inal‐Emiroglu FN, Karabay N, Resmi H, et al. Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder. J Affect Disord. 2015;182:50‐56.
    1. Inal‐Emiroglu FN, Resmi H, Karabay N, et al. Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder. Neuropsychobiology. 2015;71:140‐148.
    1. Mick E, Wozniak J, Wilens TE, Biederman J, Faraone SV. Family‐based association study of the BDNF, COMT and serotonin transporter genes and DSM‐IV bipolar‐I disorder in children. BMC Psychiatry. 2009;9:2.
    1. Mick E, Kim JW, Biederman J, et al. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1182‐1185.
    1. Gallitano AL, Tillman R, Dinu V, Geller B. Family‐based association study of early growth response gene 3 with child bipolar I disorder. J Affect Disord. 2012;138:387‐396.
    1. Geller B, Tillman R, Bolhofner K, Hennessy K, Cook EH. GAD1 single nucleotide polymorphism is in linkage disequilibrium with a child bipolar i disorder phenotype. J Child Adolesc Psychopharmacol. 2007;18:25‐29.
    1. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH. Linkage disequilibrium of the brain‐derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2004;161:1698‐1700.
    1. Ferreira MAR, O'Donovan MC, Meng YA, et al. Collaborative genome‐wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40:1056‐1058.
    1. Croarkin PE, Luby JL, Cercy K, et al. Genetic risk score analysis in early‐onset bipolar disorder. J Clin Psychiatry. 2017.
    1. Kraepelin E. Manic‐Depressive Insanity and Paranoia. Edinburgh: E. & S. Livingstone; 1921.
    1. Parens E, Johnston J. Controversies concerning the diagnosis and treatment of bipolar disorder in children. Child Adolesc Psychiatry Ment Health. 2010;4:9.
    1. Mitchell PB. Bipolar disorder: the shift to overdiagnosis. Can J Psychiatry. 2012;57:659‐665.
    1. Subramaniapillai M, Goldstein BI, MacIntosh BJ, et al. Characterizing exercise‐induced feelings after one bout of exercise among adolescents with and without bipolar disorder. J Affect Disord. 2016;190:467‐473.
    1. Metcalfe AW, MacIntosh BJ, Scavone A, Ou X, Korczak D, Goldstein BI. Effects of acute aerobic exercise on neural correlates of attention and inhibition in adolescents with bipolar disorder. Transl Psychiatry. 2016;6:e814 .

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren